Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review
- 347 Downloads
Coronary involvement in IgG4-related disease (IgG4-RD) has been scarcely reported, and myocardial ischemia as its presenting feature is even rarer. Here, we describe an additional case with novel and relevant observations. The patient was a previously healthy, middle-aged woman who presented to the clinic with new-onset typical angina. One tumefactive lesion encasing the left anterior descending artery was found during her workup. The most common underlying malignancies with secondary cardiac involvement were rationally ruled out. Symptoms persisted despite medical treatment, and she was therefore referred to surgery. Tumor excision was successfully performed, and she received coronary bypass grafting. IgG4-related coronary arteritis with pseudotumor formation was subsequently diagnosed following the comprehensive diagnostic criteria. This condition was clinically classified as active and circulating plasmablasts were found to be increased (5480/mL), even when these were determined 38 days after surgery. A PET/CT revealed an additional hypermetabolic lymph node. She was therefore treated with rituximab as induction therapy (two 1000 mg doses, administered 15 days apart). Three months later, her disease remained clinically inactive. Circulating plasmablasts were repeated and these had dropped to 0/mL. We thereafter review the current and pertinent literature on the topic, emphasizing the previous cases with similar presenting features (n = 7). We lastly suggest that IgG4-RD should be part of the differential diagnosis of any patient with tumefactive lesions surrounding the coronary arteries, since it can initially presented as sudden cardiac death.
KeywordsCoronary arteritis Coronary artery bypass IgG4-related disease Plasmablast Rituximab
The authors are pleased to acknowledge Prof. Yoh Zen (Kobe University Hospital, Japan) for his thought-provoking remarks.
Compliance with ethical standards
- 6.Inoue D, Zen Y, Matsui O, Toshifumi G (2014) Periarterial lesions. In: Umehara H, Okazaki K, Stone JH, et al. (eds) IgG4-Related Dis. Springer, pp 107–112Google Scholar
- 9.Yamamoto M, Awakawa T, Takahashi H (2015) Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years. Ann Rheum Dis 0:1–3. doi: 10.1136/annrheumdis-2015-207625
- 15.Kan-O M, Kado Y, Sadanaga A, et al. (2013) Immunoglobulin G4-related multiple cardiovascular lesions successfully treated with a combination of open surgery and corticosteroid therapy. J Vasc Surg. 1–5. doi: 10.1016/j.jvs.2013.10.106
- 24.Benson MD, Byrne-Dugan C, Adler D et al (2015) Abstract 17623: a case of biopsy-proven immunoglobulin G4-related disease associated with multiple giant coronary artery aneurysms, peripheral arterial aneurysms, end stage renal disease, and heart failure. Circ 132:A17623–A17623Google Scholar
- 31.Urabe Y, Fujii T, Kurushima S et al (2012) Pigs-in-a-blanket coronary arteries: a case of immunoglobulin G4-related coronary periarteritis assessed by computed tomography coronary angiography, intravascular ultrasound, and positron emission tomography. Circ Cardiovasc Imaging 5:685–687. doi: 10.1161/CIRCIMAGING.112.975946 CrossRefPubMedGoogle Scholar
- 34.Oe K, Araki T, Konno T, et al. (2011) Rapid progression of coronary artery disease in a patient with retroperitoneal fibrosis. J Cardiol Cases 4:August. doi: 10.1016/j.jccase.2011.05.001
- 38.Yamamoto M, Shimizu Y, Yajima H, et al. (2015) Validation of the comprehensive diagnostic criteria for IgG4-related disease in a SMART registry. Mod Rheumatol 1–16. doi: 10.3109/14397595.2015.1069951
- 47.Della-Torre E, Feeney E, Deshpande V, et al. (2014) B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis 1–8. doi: 10.1136/annrheumdis-2014-205799